Peripheral Blood-derived Endothelial Progenitor Cell Therapy Prevented Deterioration of Chronic Kidney Disease in Rats

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2015 Jul 16

PMID 26175844

Citations 27

Authors

Tien-Hung Huang

Yen-Ta Chen

Pei-Hsun Sung

Hsin-Ju Chiang

Yung-Lung Chen

Han-Tan Chai

Sheng-Ying Chung

Tzu-Hsien Tsai

Chih-Chao Yang

Chih-Hung Chen

Yi-Ling Chen

Hsueh-Wen Chang

Cheuk-Kwan Sun

Hon-Kan Yip

Affiliations

Soon will be listed here.

Abstract

Background: This study tested the hypothesis that peripheral blood-derived endothelial progenitor cell (PBDEPC) therapy can impede the deterioration of chronic kidney disease (CKD) induced by 5/6 nephrectomy in rats.

Methods And Results: Adult-male rats (n = 30) were equally categorized into group 1 (sham control), group 2 (CKD only) and group 3 [CKD + PBDEPC (left intra-arterial (3.3 × 10(5)) and penile vein (6.7 × 10(5)) injections by day 14 after CKD induction]. By day 60, kidney blood flow (KBF) was significantly lower in group 2 than that in groups 1 and 3, and significantly lower in group 3 than that in group 1, whereas the levels of serum creatinine, and kidney injury score and size showed an opposite pattern compared to that of KBF among all groups (all p < 0.001). Protein expressions of apoptotic (caspase 3, PARP), inflammatory (TNF-α, MMP-9), oxidative-stress (oxidized protein, NOX-1), fibrotic (Smad3, TGF-β), and hypoxic/ischemic cell-stress (HIF-1α, p-Akt) biomarkers showed an opposite pattern, whereas angiogenesis at protein (eNOS, CD31) and cellular (CD31+, CXCR4+) levels showed an identical pattern compared to that of blood flow in all groups (all p < 0.01). Other pro-angiogenic biomarkers (SDF-1α, CXCR4, VEGF) at protein and cellular levels and antioxidants (HO-1+, NQO 1, GR+) at cellular level showed progressive significant increase from groups 1 to 3 (all p < 0.001).

Conclusion: The results support that PBDEPC therapy effectively inhibits the propagation of CKD and the deterioration of renal function through enhancement of angiogenesis, blood flow, and anti-oxidative capacity as well as suppression of inflammation, oxidative stress, apoptosis, and fibrosis in a rodent model.

Citing Articles

Cell therapy in kidney diseases: advancing treatments for renal regeneration.

Salybekov A, Kinzhebay A, Kobayashi S Front Cell Dev Biol. 2024; 12:1505601.

PMID: 39723242 PMC: 11669058. DOI: 10.3389/fcell.2024.1505601.

Anti-inflammatory Prowess of endothelial progenitor cells in the realm of biology and medicine.

Hassanpour M, Salybkov A, Kobayashi S, Asahara T NPJ Regen Med. 2024; 9(1):27.

PMID: 39349482 PMC: 11442670. DOI: 10.1038/s41536-024-00365-z.

SGLT2 inhibitor downregulated oxidative stress via activating AMPK pathway for cardiorenal (CR) protection in CR syndrome rodent fed with high protein diet.

Yang C, Chen K, Yue Y, Cheng B, Hsu T, Chiang J J Mol Histol. 2024; 55(5):803-823.

PMID: 39190032 PMC: 11464616. DOI: 10.1007/s10735-024-10233-1.

Endothelial progenitor cells for diabetic cardiac and kidney disease.

Raleigh M, Pasricha S, Nauth A, Ward M, Connelly K Stem Cells Transl Med. 2024; 13(7):625-636.

PMID: 38733609 PMC: 11227977. DOI: 10.1093/stcltm/szae025.

Causal effects of systemic inflammatory regulators on chronic kidney diseases and renal function: a bidirectional Mendelian randomization study.

Li H, Li M, Liu C, He P, Dong A, Dong S Front Immunol. 2023; 14:1229636.

PMID: 37711613 PMC: 10498994. DOI: 10.3389/fimmu.2023.1229636.

References

Yip H, Chang Y, Wallace C, Chang L, Tsai T, Chen Y . Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury. J Pineal Res. 2012; 54(2):207-21. DOI: 10.1111/jpi.12020. View

Viberti G, Wheeldon N . Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect. Circulation. 2002; 106(6):672-8. DOI: 10.1161/01.cir.0000024416.33113.0a. View

El-Nahas A . Plasticity of kidney cells: role in kidney remodeling and scarring. Kidney Int. 2003; 64(5):1553-63. DOI: 10.1046/j.1523-1755.2003.00255.x. View

Wolf D, Reinhard A, Seckinger A, Katus H, Kuecherer H, Hansen A . Dose-dependent effects of intravenous allogeneic mesenchymal stem cells in the infarcted porcine heart. Stem Cells Dev. 2008; 18(2):321-9. DOI: 10.1089/scd.2008.0019. View

Mogensen C, Neldam S, Tikkanen I, Oren S, Viskoper R, Watts R . Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ. 2000; 321(7274):1440-4. PMC: 27545. DOI: 10.1136/bmj.321.7274.1440. View

Iwasaki H, Kawamoto A, Ishikawa M, Oyamada A, Nakamori S, Nishimura H . Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation. 2006; 113(10):1311-25. DOI: 10.1161/CIRCULATIONAHA.105.541268. View

Schachinger V, Assmus B, Erbs S, Elsasser A, Haberbosch W, Hambrecht R . Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial.... Eur J Heart Fail. 2009; 11(10):973-9. DOI: 10.1093/eurjhf/hfp113. View

Chen Y, Cheng B, Ko S, Chen C, Tsai T, Leu S . Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease. Clin Exp Nephrol. 2012; 17(1):83-91. DOI: 10.1007/s10157-012-0664-9. View

Tonelli M, Moye L, Sacks F, Kiberd B, Curhan G . Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann Intern Med. 2003; 138(2):98-104. DOI: 10.7326/0003-4819-138-2-200301210-00010. View

10.

Leu S, Sun C, Sheu J, Chang L, Yuen C, Yen C . Autologous bone marrow cell implantation attenuates left ventricular remodeling and improves heart function in porcine myocardial infarction: an echocardiographic, six-month angiographic, and molecular-cellular study. Int J Cardiol. 2010; 150(2):156-68. DOI: 10.1016/j.ijcard.2010.03.007. View

11.

Suwaidi J, Reddan D, Williams K, Pieper K, Harrington R, Califf R . Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002; 106(8):974-80. DOI: 10.1161/01.cir.0000027560.41358.b3. View

12.

Chade A, Zhu X, Lavi R, Krier J, Pislaru S, Simari R . Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation. 2009; 119(4):547-57. PMC: 2758066. DOI: 10.1161/CIRCULATIONAHA.108.788653. View

13.

Mende C . Application of direct renin inhibition to chronic kidney disease. Cardiovasc Drugs Ther. 2010; 24(2):139-49. PMC: 2887501. DOI: 10.1007/s10557-010-6232-1. View

14.

Yeh K, Sheu J, Lin Y, Sun C, Chang L, Kao Y . Benefit of combined extracorporeal shock wave and bone marrow-derived endothelial progenitor cells in protection against critical limb ischemia in rats. Crit Care Med. 2011; 40(1):169-77. DOI: 10.1097/CCM.0b013e31822d74d0. View

15.

Chen Y, Sun C, Lin Y, Chang L, Chen Y, Tsai T . Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. J Transl Med. 2011; 9:51. PMC: 3112438. DOI: 10.1186/1479-5876-9-51. View

16.

Tendera M, Wojakowski W, Ruzyllo W, Chojnowska L, Kepka C, Tracz W . Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by.... Eur Heart J. 2009; 30(11):1313-21. DOI: 10.1093/eurheartj/ehp073. View

17.

Laliberte F, Bookhart B, Vekeman F, Corral M, Duh M, Bailey R . Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. J Manag Care Pharm. 2009; 15(4):312-22. PMC: 10437749. DOI: 10.18553/jmcp.2009.15.4.312. View

18.

Jie K, Zaikova M, Bergevoet M, Westerweel P, Rastmanesh M, Blankestijn P . Progenitor cells and vascular function are impaired in patients with chronic kidney disease. Nephrol Dial Transplant. 2010; 25(6):1875-82. DOI: 10.1093/ndt/gfp749. View

19.

Assmus B, Rolf A, Erbs S, Elsasser A, Haberbosch W, Hambrecht R . Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail. 2009; 3(1):89-96. DOI: 10.1161/CIRCHEARTFAILURE.108.843243. View

20.

Reis S, Olson M, Fried L, Reeser V, Mankad S, Pepine C . Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation. 2002; 105(24):2826-9. DOI: 10.1161/01.cir.0000021597.63026.65. View